
Neuralink is planning to launch US trials translating thoughts into text
Neuralink, Elon Musk’s brain-computer interface company, is reportedly planning to start a US clinical trial in October to use its technology to translate thoughts directly into text. The trial was approved by the FDA under an investigational device exemption, and it could help pave the way for people with speech